XML 23 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 3,768 $ 3,866 $ 3,954
Cost of sales (3,236) (3,335) (3,467)
Gross margin 532 531 487
Selling, general and administrative expenses (202) (207) (207)
Restructuring, net (8) (32) (5)
Interest expense (13) (15) (17)
Interest income 22 17 10
Equity in net income (loss) of non-consolidated affiliates 8 (3) (10)
Other income (loss), net (1) 7 (1)
Income (loss) before income taxes 338 298 257
Benefit from (provision for) income taxes (125) 8 330
Net income (loss) 213 306 587
Less: Net (income) loss attributable to non-controlling interests (12) (10) (19)
Net income (loss) attributable to Visteon Corporation $ 201 $ 296 $ 568
Basic earnings per share attributable to Visteon Corporation (in dollars per share) $ 7.39 $ 10.72 $ 20.21
Diluted earnings per share attributable to Visteon Corporation (in dollars per share) $ 7.28 $ 10.61 $ 19.93